N,N'-Carbonyldiimidazole (CDI) Market Report 2023–2032: Growth Trends, Key Players & Forecast
N,N'-Carbonyldiimidazole (CDI) market demonstrates steady expansion, with its valuation reaching USD 43 million in 2023 and projected to grow at a CAGR of 5.20% , reaching approximately USD 67.86 million by 2032 . This growth trajectory reflects increasing adoption in pharmaceutical and agrochemical applications, particularly in developing economies where API manufacturing capacity continues to expand. N,N'-Carbonyldiimidazole (CDI) serves as a critical coupling reagent in peptide synthesis and pharmaceutical intermediate production. Its advantage over traditional reagents like DCC (dicyclohexylcarbodiimide) - particularly in reduced byproduct formation - makes it increasingly preferred despite higher costs. Recent FDA approvals for peptide-based drugs have significantly boosted CDI utilization in GMP manufacturing environments. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/283151/global-nncarbonyldii...